We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
AUM
$1.09B
AUM Growth
+$47.3M
Cap. Flow
-$13.7M
Cap. Flow %
-1.26%
Top 10 Hldgs %
31.34%
Holding
238
New
Increased
Reduced
238
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.07M
2
NVDA icon
NVIDIA
NVDA
+$1.01M
3
AAPL icon
Apple
AAPL
+$575K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$515K
5
TSLA icon
Tesla
TSLA
+$246K

Sector Composition

Rank Sector Weight
1 Technology 34.3%
2 Financials 17.17%
3 Healthcare 15.88%
4 Communication Services 8.18%
5 Consumer Discretionary 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
51
Nasdaq
NDAQ
$51.1B
$5.91M 0.54%
80,909
-1,060
-1% -$72.4K
CI icon
52
Cigna
CI
$75.7B
$5.9M 0.54%
17,044
-223
-1% -$76.8K
NKE icon
53
Nike
NKE
$60.8B
$5.77M 0.53%
65,026
-852
-1% -$66.8K
IBM icon
54
IBM
IBM
$194B
$5.69M 0.52%
25,728
-337
-1% -$66.1K
CRH icon
55
CRH
CRH
$65.5B
$5.67M 0.52%
61,104
-801
-1% -$67.3K
ZTS icon
56
Zoetis
ZTS
$31.3B
$5.61M 0.52%
28,738
-377
-1% -$69.5K
LIN icon
57
Linde
LIN
$234B
$5.54M 0.51%
11,621
-152
-1% -$69.4K
STT icon
58
State Street
STT
$50.6B
$5.47M 0.5%
61,877
-810
-1% -$66.8K
ORCL icon
59
Oracle
ORCL
$346B
$5.41M 0.5%
31,769
-416
-1% -$60.3K
PFE icon
60
Pfizer
PFE
$143B
$5.27M 0.48%
182,019
-2,385
-1% -$69.6K
PGR icon
61
Progressive
PGR
$120B
$5.15M 0.47%
20,313
-266
-1% -$61.8K
AFL icon
62
Aflac
AFL
$63.3B
$5.08M 0.47%
45,481
-596
-1% -$60.6K
CAT icon
63
Caterpillar
CAT
$412B
$5.08M 0.47%
12,990
-170
-1% -$58.7K
MDT icon
64
Medtronic
MDT
$105B
$5.04M 0.46%
55,536
-728
-1% -$61.2K
UNH icon
65
UnitedHealth
UNH
$385B
$5.03M 0.46%
8,607
-113
-1% -$63.9K
HIG icon
66
Hartford Financial Services
HIG
$39B
$4.95M 0.45%
41,938
-550
-1% -$60.3K
BSX icon
67
Boston Scientific
BSX
$64.8B
$4.92M 0.45%
58,686
-768
-1% -$60.5K
C icon
68
Citigroup
C
$221B
$4.81M 0.44%
76,798
-1,006
-1% -$62.2K
EW icon
69
Edwards Lifesciences
EW
$48.3B
$4.75M 0.44%
71,980
-943
-1% -$68.5K
MET icon
70
MetLife
MET
$59.5B
$4.68M 0.43%
56,783
-744
-1% -$55.6K
ILMN icon
71
Illumina
ILMN
$29.8B
$4.63M 0.43%
35,539
-466
-1% -$57.5K
CNH
72
CNH Industrial
CNH
$13.2B
$4.61M 0.42%
415,281
-5,441
-1% -$55.4K
CBRE icon
73
CBRE Group
CBRE
$39.7B
$4.56M 0.42%
36,646
-481
-1% -$52.4K
BKNG icon
74
Booking.com
BKNG
$134B
$4.44M 0.41%
26,350
-350
-1% -$53.7K
PFG icon
75
Principal Financial Group
PFG
$23.2B
$4.39M 0.4%
51,154
-670
-1% -$54.1K

Similar funds

Kintegral Advisory's Q3 2024 Portfolio in Review

As of Q3 2024, Kintegral Advisory held 238 positions worth $1.09B, up 4.5% from $1.04B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Kintegral Advisory opened no new positions and made no exits, leaving the 238-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • Kintegral Advisory's biggest Q3 2024 reduction was Microsoft, cutting an estimated $1.07M.
  • Kintegral Advisory's ten largest holdings make up 31% of its $1.09B portfolio in Q3 2024.
  • Kintegral Advisory opened 0 new positions and closed 0 in Q3 2024.
  • Kintegral Advisory's portfolio value rose 4.5% quarter-over-quarter to $1.09B.

Based on Kintegral Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.